+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region

  • PDF Icon

    Report

  • 200 Pages
  • March 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5941916
The global schizoaffective drug market size was estimated to be USD 8.10 billion in 2023 and is expected to reach USD 15.32 billion by 2034 with a CAGR of 5.97% during the forecast period 2024-2034. The increasing prevalence of schizoaffective disorder, advancements in drug development, expanding mental health awareness, government initiatives and policies, technological advancements in diagnosis, patient-centric treatment approaches, and collaborations and partnerships will drive the market growth.

The schizoaffective disorder medication market is expanding due in part to the increasing frequency and incidence of this illness. More people may receive diagnoses as mental health awareness grows and diagnostic techniques advance, increasing the need for efficient drugs. For instance, in November 2023, the FDA approved Invega Trinza, a long-acting injectable treatment for schizophrenia and schizoaffective disorder, by Johnson & Johnson.

By therapeutic class, the second-generation antipsychotics segment accounted for the highest revenue-grossing segment in the global schizoaffective drug market in 2023 owing to the increased adoption of these medications, driven by their efficacy in managing both psychotic and mood symptoms, as well as their relatively favorable side effect profiles compared to first-generation antipsychotics. For instance, in October 2023, Pfizer Inc. and Acadia Pharmaceuticals will conclude the Phase 3 study for ACP-527, a long-acting injectable antipsychotic for schizophrenia and schizoaffective disorder. Additionally, the third-generation antipsychotics segment is predicted to grow at the fastest CAGR during the forecast period owing to the continual advancements in drug development, characterized by improved efficacy, reduced side effects, and a focus on addressing specific neurobiological targets associated with schizoaffective disorder.

By treatment, the oral segment accounted for the highest revenue-grossing segment in the global schizoaffective drug market in 2023 owing to the convenience and widespread patient preference for oral formulations, as well as the well-established efficacy and safety profiles of oral medications. For instance, in November 2023, Medicare Part B coverage will be added to the Abilify MyCite program by Eli Lilly and Company, therefore improving access for individuals suffering from schizophrenia and schizoaffective disorder. Additionally, the injectables segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing recognition of the advantages associated with long-acting injectable formulations in enhancing treatment adherence, ensuring consistent therapeutic levels, and addressing challenges related to medication compliance often faced in schizoaffective disorder.

By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global schizoaffective drug market in 2023 owing to the centralized nature of treatment for severe mental health conditions, with hospitals serving as key hubs for the diagnosis, management, and ongoing care of individuals with schizoaffective disorders. For instance, in September 2023, Bristol Myers Squibb and Pear Therapeutics will collaborate to develop a digital therapy application for schizophrenia, which is presently in the early phases of development. Additionally, the online pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of digital healthcare platforms, rising consumer preference for convenient and accessible medication procurement, and the global expansion of e-commerce in the pharmaceutical sector.

North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, increased awareness, and understanding of mental health issues, robust research and development activities, and a higher prevalence of diagnosed cases of schizoaffective disorder. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing recognition of mental health disorders, a growing population, rising awareness, improving access to healthcare, and ongoing efforts to reduce the stigma associated with psychiatric conditions. For instance, Novartis AG will introduce Xeplion (paliperidone palmitate), a long-acting injectable treatment for schizophrenia and schizoaffective disorder, into the European market in August 2023.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Therapeutic Class, Treatment, and End-User
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement.

Segmentation: Schizoaffective Drug Market Report 2023 - 2034

Schizoaffective Drug Market Analysis & Forecast by Therapeutic Class 2023 - 2034 (Revenue USD Bn)

  • Second-generation Antipsychotics
  • Third-generation Antipsychotics,
  • Other Therapeutic Classes

Schizoaffective Drug Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)

  • Oral
  • Injectables

Schizoaffective Drug Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

Schizoaffective Drug Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Schizoaffective Drug Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Schizoaffective Drug Market: Therapeutic Class Estimates & Trend Analysis
7.1. Therapeutic Class Segment Opportunity Analysis
7.2. Second-generation Antipsychotics
7.2.1. Second-generation Antipsychotics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Third-generation Antipsychotics
7.3.1. Third-generation Antipsychotics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Other Therapeutic Classes
7.4.1. Other Therapeutic Classes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Schizoaffective Drug Market: Treatment Estimates & Trend Analysis
8.1. Treatment Segment Opportunity Analysis
8.2. Oral
8.2.1. Oral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Injectables
8.3.1. Injectables Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Schizoaffective Drug Market: End-User Estimates & Trend Analysis
9.1. End-User Segment Opportunity Analysis
9.2. Hospitals
9.2.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Retail Pharmacies
9.3.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Online Pharmacies
9.4.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Schizoaffective Drug Market
11.1. North America Schizoaffective Drug Market
11.1.1. North America Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Schizoaffective Drug Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
11.1.4. North America Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.1.5. North America Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Schizoaffective Drug Market
11.2.1. U.S. Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Schizoaffective Drug Market
11.3.1. Canada Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12. Europe Global Schizoaffective Drug Market
12.1. Europe Global Schizoaffective Drug Market
12.1.1. Europe Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Schizoaffective Drug Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Schizoaffective Drug Market
12.2.1. Germany Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.3. UK Global Schizoaffective Drug Market
12.3.1. UK Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
12.3.3. UK Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.3.4. UK Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.4. France Global Schizoaffective Drug Market
12.4.1. France Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
12.4.3. France Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.4.4. France Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Schizoaffective Drug Market
12.5.1. Spain Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Schizoaffective Drug Market
12.6.1. Italy Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Schizoaffective Drug Market
12.7.1. Rest of Europe Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Schizoaffective Drug Market
13.1. Asia Pacific Global Schizoaffective Drug Market
13.1.1. Asia Pacific Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Schizoaffective Drug Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Schizoaffective Drug Market
13.2.1. Japan Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.3. China Global Schizoaffective Drug Market
13.3.1. China Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
13.3.3. China Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.3.4. China Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.4. India Global Schizoaffective Drug Market
13.4.1. India Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
13.4.3. India Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.4.4. India Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Schizoaffective Drug Market
13.5.1. South Korea Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Schizoaffective Drug Market
13.6.1. Australia Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Schizoaffective Drug Market
13.7.1. Rest of Asia Pacific Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14. Latin America Global Schizoaffective Drug Market
14.1. Latin America Global Schizoaffective Drug Market
14.1.1. Latin America Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Schizoaffective Drug Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Schizoaffective Drug Market
14.2.1. Brazil Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Schizoaffective Drug Market
14.3.1. Mexico Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Schizoaffective Drug Market
14.4.1. Argentina Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Schizoaffective Drug Market
14.5.1. Rest of Latin America Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15. MEA Global Schizoaffective Drug Market
15.1. MEA Global Schizoaffective Drug Market
15.1.1. MEA Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Schizoaffective Drug Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Schizoaffective Drug Market
15.2.1. GCC Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Schizoaffective Drug Market
15.3.1. South Africa Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Schizoaffective Drug Market
15.4.1. Rest of MEA Schizoaffective Drug Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Schizoaffective Drug Market Size and Forecast, By Therapeutic Class, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Schizoaffective Drug Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Schizoaffective Drug Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Johnson & Johnson
17.2. Pfizer Inc.
17.3. Eli Lilly and Company
17.4. AstraZeneca
17.5. Bristol Myers Squibb
17.6. Novartis AG
17.7. GlaxoSmithKline plc (GSK)
17.8. Otsuka Pharmaceutical Co., Ltd.
17.9. Lundbeck
17.10. Sunovion Pharmaceuticals Inc.
17.11. Alkermes plc
17.12. Allergan (now part of AbbVie)
17.13. Sumitomo Dainippon Pharma Co., Ltd.
17.14. Takeda Pharmaceutical Company Limited
17.15. Boehringer Ingelheim
18. Conclusion19. Recommendations

Companies Mentioned

  • Johnson & Johnson
  • Pfizer Inc.
  • Eli Lilly and Company
  • AstraZeneca
  • Bristol Myers Squibb
  • Novartis AG
  • GlaxoSmithKline plc (GSK)
  • Otsuka Pharmaceutical Co. Ltd.
  • Lundbeck
  • Sunovion Pharmaceuticals Inc.
  • Alkermes plc
  • Allergan (now part of AbbVie)
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim.

Table Information